.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Baxter
Harvard Business School
Deloitte
Healthtrust
Covington
McKinsey
Fish and Richardson
UBS
Cipla

Generated: September 21, 2017

DrugPatentWatch Database Preview

Amoxicillin; clavulanate potassium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for amoxicillin; clavulanate potassium and what is the scope of amoxicillin; clavulanate potassium patent protection?

Amoxicillin; clavulanate potassium
is the generic ingredient in nine branded drugs marketed by Teva, Sun Pharm Inds Ltd, Micro Labs Ltd India, Apotex Inc, Sandoz Inc, Wockhardt Eu Operatn, Dr Reddys Labs Inc, Hikma Pharms, Sandoz, Wockhardt, Aurobindo Pharma Ltd, and Teva Pharms Usa, and is included in forty-one NDAs. There are five patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Amoxicillin; clavulanate potassium has ninety-four patent family members in forty-eight countries.

There are forty-four drug master file entries for amoxicillin; clavulanate potassium. Forty-six suppliers are listed for this compound.

Summary for Generic Name: amoxicillin; clavulanate potassium

Tradenames:9
Patents:5
Applicants:12
NDAs:41
Drug Master File Entries: see list44
Suppliers / Packagers: see list46
Bulk Api Vendors: see list3
Clinical Trials: see list897
Patent Applications: see list281
Therapeutic Class:Antibacterials
Drug Prices:see low prices
DailyMed Link:amoxicillin; clavulanate potassium at DailyMed

Pharmacology for Ingredient: amoxicillin; clavulanate potassium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Inc
AUGMENTIN '200'
amoxicillin; clavulanate potassium
TABLET, CHEWABLE;ORAL050726-001May 31, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
TABLET;ORAL091569-001Jan 20, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
FOR SUSPENSION;ORAL065089-001May 25, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Inc
AUGMENTIN XR
amoxicillin; clavulanate potassium
TABLET, EXTENDED RELEASE;ORAL050785-001Sep 25, 2002ABRXYesYes► Subscribe► Subscribe ► Subscribe
Teva
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
TABLET, CHEWABLE;ORAL065205-002Feb 9, 2005RXNoYes► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
FOR SUSPENSION;ORAL201090-001Dec 20, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma Pharms
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
FOR SUSPENSION;ORAL065373-001Nov 9, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Micro Labs Ltd India
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
TABLET;ORAL204755-003Dec 30, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Inc
AUGMENTIN '200'
amoxicillin; clavulanate potassium
FOR SUSPENSION;ORAL050725-001May 31, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe
Wockhardt Eu Operatn
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
FOR SUSPENSION;ORAL065420-001Dec 2, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: amoxicillin; clavulanate potassium

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,294,199 Method of treating a bacterial infection comprising administering amoxycillin► Subscribe
6,660,299 Modified release pharmaceutical formulation comprising amoxycillin► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: amoxicillin; clavulanate potassium

Country Document Number Estimated Expiration
Romania120817► Subscribe
Japan2002541186► Subscribe
Poland197448► Subscribe
Ireland20000271► Subscribe
Norway20001870► Subscribe
Finland4823► Subscribe
South Africa200108322► Subscribe
Austria242629► Subscribe
Uruguay26104► Subscribe
South Korea20020015311► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Medtronic
Chinese Patent Office
Cantor Fitzgerald
Fish and Richardson
Covington
Mallinckrodt
Baxter
QuintilesIMS
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot